| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13264* | 2021 |
| CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization H Roca, ZS Varsos, S Sud, MJ Craig, C Ying, KJ Pienta Journal of biological chemistry 284 (49), 34342-34354, 2009 | 626 | 2009 |
| BMP signaling is required for RUNX2‐dependent induction of the osteoblast phenotype M Phimphilai, Z Zhao, H Boules, H Roca, RT Franceschi Journal of Bone and Mineral Research 21 (4), 637-646, 2006 | 456 | 2006 |
| Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer H Roca, J Hernandez, S Weidner, RC McEachin, D Fuller, S Sud, ... PloS one 8 (10), e76773, 2013 | 287 | 2013 |
| Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor C Ge, G Xiao, D Jiang, Q Yang, NE Hatch, H Roca, RT Franceschi Journal of Biological Chemistry 284 (47), 32533-32543, 2009 | 258 | 2009 |
| The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment K Mizutani, S Sud, NA McGregor, G Martinovski, BT Rice, MJ Craig, ... Neoplasia 11 (11), 1235-1242, 2009 | 255 | 2009 |
| Transcriptional regulation of osteoblasts RT Franceschi, C Ge, G Xiao, H Roca, DI Jiang Annals of the New York Academy of Sciences 1116 (1), 196-207, 2007 | 253 | 2007 |
| CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation H Roca, Z Varsos, KJ Pienta Journal of Biological Chemistry 283 (36), 25057-25073, 2008 | 190 | 2008 |
| Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis FN Soki, AJ Koh, JD Jones, YW Kim, J Dai, ET Keller, KJ Pienta, K Atabai, ... Journal of Biological Chemistry 289 (35), 24560-24572, 2014 | 161 | 2014 |
| Transcriptional regulation of osteoblasts RT Franceschi, C Ge, G Xiao, H Roca, D Jiang Cells Tissues Organs 189 (1-4), 144-152, 2008 | 161 | 2008 |
| Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone H Roca, JD Jones, MC Purica, S Weidner, AJ Koh, R Kuo, JE Wilkinson, ... The Journal of clinical investigation 128 (1), 248-266, 2018 | 120 | 2018 |
| Cooperative interactions between RUNX2 and homeodomain protein-binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene H Roca, M Phimphilai, R Gopalakrishnan, G Xiao, RT Franceschi Journal of Biological Chemistry 280 (35), 30845-30855, 2005 | 120 | 2005 |
| IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulation H Roca, MJ Craig, C Ying, ZS Varsos, P Czarnieski, AS Alva, ... Journal of cellular biochemistry 113 (5), 1569-1580, 2012 | 93 | 2012 |
| CCL2, survivin and autophagy: new links with implications in human cancer H Roca, ZS Varsos, K Mizutani, KJ Pienta Autophagy 4 (7), 969-971, 2008 | 70 | 2008 |
| Modulation of osteoblastic cell efferocytosis by bone marrow macrophages MN Michalski, AJ Koh, S Weidner, H Roca, LK McCauley Journal of cellular biochemistry 117 (12), 2697-2706, 2016 | 63 | 2016 |
| Cloning of the Penicillium minioluteum gene encoding dextranase and its expression in Pichia pastoris H Roca, B Garcia, E Rodriguez, D Mateu, L Coroas, J Cremata, R Garcia, ... Yeast 12 (12), 1187-1200, 1996 | 61 | 1996 |
| CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells H Roca, ZS Varsos, KJ Pienta Neoplasia 11 (12), 1309-1317, 2009 | 55 | 2009 |
| Synapsis, strand scission, and strand exchange induced by the FLP recombinase: analysis with half-FRT sites A Amin, H Roca, K Luetke, PD Sadowski Molecular and cellular biology 11 (9), 4497-4508, 1991 | 54 | 1991 |
| Immune mediators in the tumor microenvironment of prostate cancer J Dai, Y Lu, H Roca, JM Keller, J Zhang, LK McCauley, ET Keller Chinese journal of cancer 36, 1-8, 2017 | 53 | 2017 |
| Trabectedin reduces skeletal prostate cancer tumor size in association with effects on M2 macrophages and efferocytosis JD Jones, BP Sinder, D Paige, FN Soki, AJ Koh, S Thiele, Y Shiozawa, ... Neoplasia 21 (2), 172-184, 2019 | 52 | 2019 |
